ZILAD Zila (MM)

Zila, Inc. (Nasdaq:ZILAD) today announced that it will release its financial results for the fiscal 2008 fourth quarter and full year ended July 31, 2008, after the market closes on Monday, October 6, 2008. The company also said that senior management will host an investor conference call that day at 1:30 p.m. PT (4:30 p.m. ET) to review the company�s financial results. The conference call will be available to interested parties through a live audio Internet broadcast at www.zila.com and www.opencompany.info. The call will also be archived and accessible at both sites for approximately 90 days. Alternatively, callers may participate in the conference call by dialing (800) 240-5318 (domestic) or (303) 262-2139 (international). A telephonic replay will be available for approximately 48 hours following the conclusion of the call by dialing (800) 405-2236 (domestic) or (303) 590-3000 (international), and entering passcode 11120444#. About Zila, Inc. Zila, Inc., is a fully integrated oral diagnostic company dedicated to the prevention, detection and treatment of oral cancer and periodontal disease. ViziLite� Plus, the company's flagship product for the early detection of oral abnormalities that could lead to cancer, is the first and only adjunctive medical device cleared by the FDA for use in a population at increased risk for oral cancer. In addition, Zila designs, manufactures and markets a suite of proprietary products sold exclusively and directly to dental professionals for periodontal disease, including the Rotadent� Professional Powered Brush, the Pro-Select Platinum� ultrasonic scaler and a portfolio of oral pharmaceutical products for both in-office and home-care use. For more information about the company and its products, please visit www.zila.com.